Irinotecan (CPT-11) High-Dose Escalation Using Intensive High-Dose Loperamide to Control Diarrhea

洛哌丁胺 腹泻 医学 伊立替康 毒性 胃肠病学 化疗 内科学 麻醉 结直肠癌 癌症
作者
D Abigerges,P. Armand,G G Chabot,Leonardo Dourado da Costa,Élie Fadel,Claudia Côté,Patrice Herait,Daniel Gandía
出处
期刊:Journal of the National Cancer Institute [Oxford University Press]
卷期号:86 (6): 446-449 被引量:245
标识
DOI:10.1093/jnci/86.6.446
摘要

BACKGROUND: Diarrhea is a serious side effect that may prevent the administration of high doses of the antitumor drug Irinotecan (CPT-11). PURPOSE: Intensive, high-dose loperamide was used in an attempt to control or downstage CPT-11-induced diarrhea and thus permit the use of higher dose intensities of CPT-11. METHODS: Twenty-three patients with various cancers were treated with doses of CPT-11 ranging from 400 to 600 mg/m2, administered as a 30-minute intravenous infusion every 3 weeks. Starting 8 hours or more after the administration of CPT-11, any episode of diarrhea was treated with 2 mg of loperamide taken every 2 hours. Patients stopped taking loperamide only after a 12-hour diarrhea-free period. If diarrhea was not controlled after 3 consecutive days of nonstop loperamide intake, or if the patient was dehydrated, loperamide was stopped and the patient was hospitalized for intravenous fluids. If blood or mucus were found in the stools at any time during diarrhea, loperamide was stopped and the patient was hospitalized. RESULTS: Seventeen of 23 patients had diarrhea while on CPT-11 treatment. Eighty-two CPT-11 cycles were administered to these 17 patients, and diarrhea occurred in 49 of these cycles, at a median time-to-onset of 6 days after CPT-11 administration. The loperamide protocol was followed in 46 of the 49 episodes of diarrhea, with 21 capsules of loperamide the median number being taken (range, 5-72). Only one patient was hospitalized for failure to respond to loperamide, and no major toxicity was associated with loperamide use. Fourteen of the 17 patients who experienced diarrhea were rechallenged with CPT-11 three or more times, and seven patients six or more times. CONCLUSIONS: High-dose loperamide controlled diarrhea in patients receiving CPT-11 and allowed administration of higher doses of CPT-11. IMPLICATIONS: The effectiveness of CPT-11 might be increased by higher dose intensities, which can be made tolerable by control of diarrhea with loperamide.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
冷静新烟发布了新的文献求助10
刚刚
renyi发布了新的文献求助10
刚刚
linjiebro完成签到,获得积分10
刚刚
NexusExplorer应助yjh1515790968采纳,获得10
1秒前
深情安青应助Mila采纳,获得10
1秒前
CodeCraft应助蓝莓西西果冻采纳,获得10
2秒前
石语芙发布了新的文献求助20
2秒前
2秒前
Toooo发布了新的文献求助10
2秒前
ernest发布了新的文献求助10
2秒前
2秒前
轻松的寒风完成签到,获得积分10
2秒前
哇啊娃娃啊完成签到,获得积分10
3秒前
李健的粉丝团团长应助mg采纳,获得10
3秒前
温婉的凌寒完成签到,获得积分10
3秒前
rico应助yiiqianzhang采纳,获得40
3秒前
毛毛余发布了新的文献求助10
4秒前
投石问路发布了新的文献求助10
4秒前
Psyche完成签到,获得积分10
4秒前
科研通AI6.4应助zxq采纳,获得10
4秒前
鲨鱼发布了新的文献求助10
4秒前
LLL完成签到,获得积分10
5秒前
5秒前
Tumumu完成签到,获得积分0
5秒前
Li完成签到 ,获得积分10
5秒前
6秒前
李爱国应助桃月二九采纳,获得10
6秒前
舒适一笑完成签到,获得积分10
6秒前
7秒前
情怀应助博修采纳,获得10
7秒前
纪元龙发布了新的文献求助10
7秒前
李哈哈发布了新的文献求助10
7秒前
8秒前
8秒前
8秒前
8秒前
希望天下0贩的0应助Oliver采纳,获得10
8秒前
bkagyin应助鲨鱼采纳,获得10
9秒前
10秒前
yiiqianzhang完成签到,获得积分10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Organic Reactions, Volume 116 1500
VALIDATION OF THE TAYLOR, ALAMEL AND VPSC MODELS FOR PLASTIC ANISOTROPY MODELING OF SHEET METALS 1000
Geist der Kunst und Kultur 1000
Middleton's Allergy Principles and Practice 10th Edition(Middleton's Allergy 2-Volume Set, 10th Edition) 1000
Resistance Spot Welding Dataset for Automobile Body-in-White Quality Analysis 748
日本現代怪異事典 副読本 700
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7402863
求助须知:如何正确求助?哪些是违规求助? 9007473
关于积分的说明 19178403
捐赠科研通 7036374
什么是DOI,文献DOI怎么找? 3231347
关于科研通互助平台的介绍 2393698
邀请新用户注册赠送积分活动 2213124